India’s USD 30.5-billion pharmaceutical export industry, which supplies medicines to more than 200 countries, could soon see tighter oversight of one of its least regulated
New Delhi: The Central government has ordered an immediate ban on 16 Fixed Dose Combination (FDC) drugs for human use, stating that use is ‘likely
For someone with a dangerous tumor, surgical removal of the cancer may bring immediate relief but leave the person with an uncertain future. Sometimes, remnant
Industry associations have urged the government to make effective use of the substantial unutilised capacity available with domestic Active Pharmaceutical Ingredient (API) manufacturers. This, according
For years, doctors around the world have been locked in a race against a terrifying enemy — bacteria that have learnt how to outsmart medicines.These
India’s ambition to become a global hub for advanced pharmaceuticals will depend on how effectively it balances affordability with a policy environment that supports innovation-led
June 11 (Reuters) – India has given the go-ahead to a regulator for raising prices of platinum-based cancer drugs that have been in short supply
India’s pharmaceutical sector is entering a defining phase in its evolution. For decades, the country has been recognised globally for its scale, reliability and quality
The Indian Pharmaceutical Market (IPM) is entering a transformative phase where traditional healthcare engagement models may no longer be sufficient to connect with the country’s
Spurred by the success of RevMed, numerous companies are now racing to develop similar drugs, dubbed “molecular glues”, which can be used to treat a
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump